Evidence map›Paper›PMID 32911682›Full record

ReviewPharmaceuticals (Basel, Switzerland)2020

The Role of Adaptogens in Prophylaxis and Treatment of Viral Respiratory Infections.

Alexander Panossian, Thomas Brendler

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04795557 phase2 / phase3completednot on this mapstarted 2021, after this paper: background citation

Effect of ADAPT232 Supplementation on Recovery of Patients in Rehabilitation Period in Long COVID-19: a Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorSwedish Herbal Institute ABRan2021 to 2021Enrolled100ConditionsCovid19ArmsADAPT-232 oral solution, Placebo oral solution
NCT04847518 phase2 / phase3unknown statusnot on this mapstarted 2021, after this paper: background citation

Effect of Kan-Jang® Supplementation in Patients Diagnosed With COVID-19: A Randomized, Quadruple-blind, Placebo-controlled Trial

TypeinterventionalSponsorSwedish Herbal Institute ABRan2021 to 2022Enrolled140ConditionsCovid19ArmsKan Jang capsules, Placebo capsules
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Effects ofNutrients · 2026
    Pooled it
  2. [Herbal treatment options for post-viral symptoms and long COVID].Wiener medizinische Wochenschrift (1946) · 2026
    Review
  3. Review
  4. Molecules (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. The EPMA journal · 2024
    Review
  10. Article
  11. Efficacy of Kan JangPharmaceuticals (Basel, Switzerland) · 2023
    Article
  12. Phenolic Compounds ofInternational journal of molecular sciences · 2023
    Review
  13. Extract ofMolecules (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Efficacy of Kan JangPharmaceuticals (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Article
  18. Revisiting liquorice (Phytomedicine plus : international journal of phytotherapy and phytopharmacology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Alexander PanossianPhytomed AB, Vaxtorp, 31275 Halland, Sweden.ORCID 0000-0002-8467-4525
Thomas BrendlerDepartment of Botany and Plant Biotechnology, University of Johannesburg, Johannesburg 2000, South Africa.ORCID 0000-0002-1105-5838
University of Johannesburg · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of our review is to demonstrate the potential of herbal preparations, specifically adaptogens for prevention and treatment of respiratory infections, as well as convalescence, specifically through supporting a challenged immune system, increasing resistance to viral infection, inhibiting severe inflammatory progression, and driving effective recovery. The evidence from pre-clinical and clinical studies with

Indexed as

adaptogensAndrographisEleutherococcusGlycyrrhizamelatoninPanaxRhodiolaSchisandraviral infectionWithania

Identifiers

PMID32911682
PMCPMC7558817
OpenAlexW3084126546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.